D. Cattaneo

N. Perico, G. Remuzzi, E. Gotti, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of combining ACE inhibitor and statin in severe experimental nephropathy.

G. Remuzzi, M. Abbate, D. Cattaneo, 2002, Kidney international.

Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure

E. Clementi, I. Cetin, D. Cattaneo, 2019, Front. Pediatr..

Long-term Renal Effects of Tenofovir-Disoproxil-Fumarate in Vertically HIV-Infected Children, Adolescents, and Young Adults: A 132-Month Follow-Up Study

G. Bedogni, P. Erba, G. Zuccotti, 2015, Clinical Drug Investigation.

Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy?

E. Clementi, D. Cattaneo, M. Puoti, 2016, The Journal of antimicrobial chemotherapy.

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients.

E. Clementi, D. Cattaneo, G. Rizzardini, 2012, Pharmacological research.

Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes

G. Remuzzi, B. Ene-Iordache, P. Ruggenenti, 2010, Diabetes Care.

Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection.

N. Perico, F. Gaspari, D. Cattaneo, 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Lack of clinically relevant interactions between bictegravir and metformin in persons with diabetes and HIV.

D. Cattaneo, C. Gervasoni, P. Meraviglia, 2021, The Journal of antimicrobial chemotherapy.

How Relevant is the Interaction Between Dolutegravir and Metformin in Real Life?

E. Clementi, D. Cattaneo, G. Rizzardini, 2017, Journal of acquired immune deficiency syndromes.

The prescribing cascade 3.0: a case for recreational drugs in HIV.

D. Cattaneo, G. Rizzardini, C. Gervasoni, 2020, AIDS.

Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients.

D. Cattaneo, M. Falcone, A. Di Paolo, 2020, The Journal of antimicrobial chemotherapy.

Does immunoglobulin A nephropathy affect long-term graft outcome after kidney transplantation?

D. Cattaneo, 2007, Journal of postgraduate medicine.

Kidney injury molecule 1: in search of biomarkers of chronic tubulointerstitial damage and disease progression.

N. Perico, G. Remuzzi, D. Cattaneo, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment

E. Clementi, A. de Silvestri, D. Cattaneo, 2021, The Pharmacogenomics Journal.

Renal function in HIV/HBV co‐infected and HBV mono‐infected patients on a long‐term treatment with tenofovir in real life setting

S. Antinori, D. Cattaneo, C. Mazzali, 2017, Clinical and experimental pharmacology & physiology.

Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients

E. Clementi, M. Gismondo, D. Cattaneo, 2014, ClinicoEconomics and outcomes research : CEOR.

Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living with HIV: a narrative review.

E. Clementi, D. Marriott, D. Cattaneo, 2020, Therapeutic drug monitoring.

Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor

D. Cattaneo, C. Gervasoni, 2018, European Journal of Drug Metabolism and Pharmacokinetics.

Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial.

E. Clementi, A. Lazzarin, D. Cattaneo, 2018, The new microbiologica.

Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?

E. Clementi, D. Cattaneo, N. Charbe, 2015, PloS one.

Pharmacogenetics and pharmacogenomics of immunosuppressive agents: perspective for individualized therapy.

N. Perico, G. Remuzzi, D. Cattaneo, 2004, Personalized medicine.

Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.

D. Cattaneo, D. Ricaboni, C. Gervasoni, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Practices of therapeutic drug monitoring in tuberculosis: an international survey

D. Cattaneo, Y. Stienstra, D. Goletti, 2022, European Respiratory Journal.

Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?

E. Clementi, D. Cattaneo, C. Gervasoni, 2016, European Respiratory Journal.

Effects of Rosuvastatin on Glomerular Capillary Size-Selectivity Function in Rats with Renal Mass Ablation

N. Perico, G. Remuzzi, A. Remuzzi, 2007, American Journal of Nephrology.

Limited sampling strategies for the estimation of atazanavir daily exposure in HIV‐infected patients

E. Clementi, D. Cattaneo, D. Ripamonti, 2013, Fundamental & clinical pharmacology.

Atypical pharmacokinetics of atazanavir in an HIV‐1‐infected patient

E. Clementi, D. Cattaneo, S. Baldelli, 2012, Fundamental & clinical pharmacology.

Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding

E. Clementi, D. Cattaneo, R. Beretta, 2011, European Journal of Clinical Pharmacology.

E. Clementi, D. Cattaneo, C. Gervasoni, 2015, European Journal of Clinical Pharmacology.

PHARMACOKINETICS OF MYCOPHENOLATE SODIUM AND COMPARISON WITH THE MOFETIL FORMULATION IN KIDNEY TRANSPLANT RECIPIENTS.

N. Perico, G. Remuzzi, E. Gotti, 2006, Clinical journal of the American Society of Nephrology : CJASN.

When the absence of an interaction can become clinically relevant.

D. Cattaneo, C. Gervasoni, Chiara Resnati, 2021, AIDS.

Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones

M. Neely, D. Cattaneo, J. Alffenaar, 2016, Expert opinion on drug metabolism & toxicology.

Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.

D. Marriott, M. Neely, D. Cattaneo, 2020, Therapeutic drug monitoring.

Loss of Control of HIV Viremia With OTC Weight‐Loss Drugs: A Call for Caution?

A. Giacomelli, D. Cattaneo, C. Gervasoni, 2018, Obesity.

The aggravating mechanisms of aldosterone on kidney fibrosis.

N. Perico, G. Remuzzi, D. Cattaneo, 2008, Journal of the American Society of Nephrology : JASN.

No effects of Hypericum-containing complex on dolutegravir plasma trough concentrations: a case report

D. Cattaneo, C. Gervasoni, M. Fusi, 2019, European Journal of Clinical Pharmacology.

Nephrotoxic aspects of cyclosporine.

N. Perico, G. Remuzzi, F. Gaspari, 2004, Transplantation proceedings.

The Relevance of Drug–drug Interactions in Clinical Practice: The Case of Concomitant Boosted Protease Inhibitors plus Alpha-1 Blocker Administration

D. Cattaneo, C. Gervasoni, Chiara Resnati, 2018, Antiviral therapy.

DeltaNp63 expression is associated with poor survival in ovarian cancer.

A. Lissoni, M. Broggini, D. Cattaneo, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

D Np 63 expression is associated with poor survival in ovarian cancer

A. Lissoni, M. Broggini, D. Cattaneo, 2008 .

DNp63 expression is associated with poor survival in ovarian cancer

A. Lissoni, M. Broggini, D. Cattaneo, 2008 .

Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios

D. Cattaneo, G. Marchetti, M. Di Luca, 2022, Expert review of anti-infective therapy.

Is it time to revise linezolid doses in peritoneal dialysis patients? A case series.

E. Clementi, R. Bergia, D. Cattaneo, 2015, Journal of Antimicrobial Chemotherapy.

Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy

A. Giacomelli, S. Antinori, A. Maggioni, 2020, Drugs & Aging.

Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience.

D. Cattaneo, C. Gervasoni, A. Gidaro, 2020, Seminars in thrombosis and hemostasis.

Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts

M. Corbellino, D. Cattaneo, C. Gervasoni, 2020, European journal of clinical pharmacology.

Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?

E. Clementi, M. Corbellino, D. Cattaneo, 2020, The Journal of antimicrobial chemotherapy.

Does lopinavir really inhibit SARS-CoV-2?

E. Clementi, M. Corbellino, D. Cattaneo, 2020, Pharmacological Research.

Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients

S. Antinori, A. Maggioni, D. Cattaneo, 2021, Drugs & Aging.

Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.

E. Clementi, D. Cattaneo, V. Russo, 2021, Clinical therapeutics.

ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?

E. Clementi, D. Cattaneo, L. Ferraris, 2013, European Journal of Clinical Pharmacology.

Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.

N. Perico, G. Remuzzi, F. Gaspari, 2003, Journal of the American Society of Nephrology : JASN.

Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes.

E. Clementi, G. Zuccotti, D. Cattaneo, 2013, The Pediatric infectious disease journal.

Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

M. Neely, D. Cattaneo, I. Sandaradura, 2021, Therapeutic drug monitoring.

Regulatory T cells and T cell depletion: role of immunosuppressive drugs.

N. Perico, G. Remuzzi, F. Gaspari, 2007, Journal of the American Society of Nephrology : JASN.

Therapeutic Drug Monitoring of Sirolimus: Effect of Concomitant Immunosuppressive Therapy and Optimization of Drug Dosing

N. Perico, G. Remuzzi, F. Gaspari, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples

D. Cattaneo, A. Bandera, L. Alagna, 2021, Journal of chemotherapy.

Identification of Different Patterns of Dabigatran In Vivo Bioactivation in Patients on Maintenance Anticoagulation Therapy.

E. Clementi, D. Cattaneo, F. Violi, 2016, Therapeutic drug monitoring.

The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice: Erratum.

E. Clementi, D. Cattaneo, F. Violi, 2016, Therapeutic drug monitoring.

Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy

P. Striano, M. Galli, F. Zara, 2018, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.

Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.

B. Tönshoff, J. Chapman, D. Cattaneo, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Reply to 'Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients'.

D. Cattaneo, C. Gervasoni, 2011, AIDS.

Comparison of the Pharmacokinetics of Raltegravir Given at 2 Doses of 400 mg by Swallowing Versus One Dose of 800 mg by Chewing in Healthy Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Phase 1 Study

E. Clementi, D. Cattaneo, A. Riva, 2015, Therapeutic drug monitoring.

Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Raltegravir in HIV Patients Receiving the Drug by Swallowing or by Chewing

E. Clementi, D. Cattaneo, A. Gazzaniga, 2012, Antimicrobial Agents and Chemotherapy.

Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV‐Infected Patients

E. Clementi, D. Cattaneo, D. Ripamonti, 2012, Journal of clinical pharmacology.

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects.

E. Clementi, D. Cattaneo, M. Galli, 2012, The Journal of antimicrobial chemotherapy.

E. Clementi, D. Cattaneo, D. Ripamonti, 2010, Therapeutic drug monitoring.

Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey

D. Cattaneo, Jana Stojanova, D. Marriott, 2022, Frontiers in Pharmacology.

Two-hour post dose cyclosporine monitoring does not fit all in kidney transplantation

N. Perico, G. Remuzzi, F. Gaspari, 2005 .

Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer

D. Cattaneo, F. Maggiolo, D. Ripamonti, 2007, AIDS.

Let's assume that hepatitis C reduces the cardiovascular risk in dialysis patients: are there practical implications?

N. Perico, G. Remuzzi, D. Cattaneo, 2006, Journal of Hepatology.

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy

E. Clementi, A. Giacomelli, D. Cattaneo, 2018, BMC Infectious Diseases.

Clinical and genetic determinants of nevirapine plasma trough concentration

E. Clementi, A. Giacomelli, D. Cattaneo, 2018, SAGE open medicine.

Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study

E. Clementi, V. Fabiano, G. Zuccotti, 2017, Therapeutic drug monitoring.

Therapeutic Drug Monitoring of Antibiotics in the Elderly: A Narrative Review

D. Cattaneo, M. Falcone, C. Gervasoni, 2021, Therapeutic drug monitoring.

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

P. Marquet, D. Cattaneo, A. Vinks, 2011, Transplantation reviews.

Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients.

N. Perico, G. Remuzzi, F. Gaspari, 2001, Clinical chemistry.

C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.

N. Perico, G. Remuzzi, E. Gotti, 2007, Pharmacogenomics.

Mycophenolic Acid Formulation Affects Cyclosporine Pharmacokinetics in Stable Kidney Transplant Recipients

N. Perico, G. Remuzzi, E. Gotti, 2006, Therapeutic Drug Monitoring.

Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation.

N. Perico, G. Remuzzi, E. Gotti, 2005, Clinica chimica acta; international journal of clinical chemistry.

Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection.

N. Perico, D. Cattaneo, S. Baldelli, 2006, Clinica chimica acta; international journal of clinical chemistry.

Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation.

N. Perico, G. Remuzzi, F. Gaspari, 2002, Kidney international.

Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review

N. Latronico, D. Cattaneo, A. Corona, 2022, Antibiotics.

Development of an HPLC–UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients☆

E. Clementi, D. Cattaneo, N. Charbe, 2016, Journal of pharmaceutical analysis.

Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation.

G. Remuzzi, M. Morigi, D. Cattaneo, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome.

N. Perico, G. Remuzzi, M. Salvadori, 2009, Journal of the American Society of Nephrology : JASN.

“CATCH” Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study

D. Cattaneo, A. Corona, S. Santini, 2022, Antibiotics.

Contents Vol. 27, 2007

J. McGill, W. Bolton, N. Perico, 2007, American Journal of Nephrology.

Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Different Formulations in Stable Renal Transplant Patients

D. Cattaneo, 2008 .

Development of a CE method for the determination of mycophenolic acid in human plasma: A comparison with HPLC

D. Cattaneo, M. Anzini, M. Rovini, 2007, Electrophoresis.

Effect of Cobicistat on Tenofovir Disoproxil Fumarate (TDF): What Is True for TAF May Also Be True for TDF

E. Clementi, A. Giacomelli, D. Cattaneo, 2017, Journal of acquired immune deficiency syndromes.

Omega-3 polyunsaturated fatty acids affect sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen.

N. Perico, G. Remuzzi, E. Gotti, 2010, Transplantation.

Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience

E. Clementi, D. Cattaneo, S. Baldelli, 2020, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings

E. Clementi, M. Molteni, D. Cattaneo, 2016, European Journal of Clinical Pharmacology.

Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study

E. Clementi, D. Cattaneo, C. Zucca, 2022, Epilepsy & Behavior.

Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis

E. Clementi, A. Giacomelli, D. Cattaneo, 2019, Clinical Pharmacokinetics.

Intraindividual and Interindividual Variability of Olanzapine Trough Concentrations in Patients Treated With the Long-Acting Injectable Formulation

E. Clementi, D. Cattaneo, M. Mauri, 2018, Journal of clinical psychopharmacology.

Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics?

E. Clementi, D. Cattaneo, S. Baldelli, 2017, Pharmacopsychiatry.

Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement.

M. Colaneri, D. Cattaneo, M. Fabbiani, 2020, Journal of Antimicrobial Chemotherapy.

Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients.

E. Clementi, D. Cattaneo, A. Gazzaniga, 2016, Therapeutic drug monitoring.

Comparison of the QMS Analyzer With HPLC-UV for the Quantification of Lamotrigine Concentrations in Human Plasma Samples

E. Clementi, D. Cattaneo, N. Charbe, 2015, Therapeutic drug monitoring.

Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations

D. Cattaneo, C. Gervasoni, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

Generic cyclosporine formulations: more open questions than answers

N. Perico, G. Remuzzi, D. Cattaneo, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review

D. Cattaneo, A. Corona, C. Gervasoni, 2022, Antibiotics.

Determination of Linezolid in Human Plasma by High-Performance Liquid Chromatography With Ultraviolet Detection

E. Clementi, D. Cattaneo, S. Baldelli, 2010, Therapeutic drug monitoring.

The management of anti-infective agents in intensive care units: the potential role of a ‘fast’ pharmacology

D. Marriott, D. Cattaneo, A. Corona, 2020, Expert review of clinical pharmacology.

Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study

A. Giacomelli, S. Antinori, C. Cogliati, 2020, medRxiv.

Hepatitis C infection and chronic renal diseases.

B. Bikbov, N. Perico, G. Remuzzi, 2009, Clinical journal of the American Society of Nephrology : CJASN.

D. Cattaneo, C. Gervasoni, N. Zanchetta, 2017, Antiviral therapy.

Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events

E. Clementi, D. Cattaneo, A. Riva, 2013, PloS one.

Drug–drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment

D. Cattaneo, G. Rizzardini, A. Capetti, 2019, Expert opinion on drug metabolism & toxicology.

A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries.

D. Cattaneo, C. Perno, G. Rizzardini, 2018, AIDS.

Population pharmacokinetics and target attainment analysis of linezolid in multidrug‐resistant tuberculosis patients

D. Cattaneo, S. Wicha, S. Baldelli, 2021, British journal of clinical pharmacology.

In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5.

E. Clementi, A. de Silvestri, D. Cattaneo, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?

D. Cattaneo, Ottavia Viganò, T. Bini, 2020, Therapeutic drug monitoring.

Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma

Matteo Cerea, Sara Baldelli, Giorgio Marrubini, 2017, Therapeutic drug monitoring.

Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV

D. Cattaneo, G. di Perri, A. Calcagno, 2020, Clinical Pharmacokinetics.

When food can make the difference: The case of elvitegravir-based co-formulation.

E. Clementi, D. Cattaneo, M. Galli, 2016, International journal of pharmaceutics.

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data

J. Proost, W. Bierman, J. Kosterink, 2018, Therapeutic drug monitoring.

Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV

D. Cattaneo, G. Rizzardini, M. Cossu, 2019, Expert opinion on drug metabolism & toxicology.

Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference

E. Clementi, D. Cattaneo, A. Riva, 2017, The Journal of antimicrobial chemotherapy.

Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count

D. Cattaneo, G. Zehender, L. Milazzo, 2014, Journal of medical virology.

Drug-induced liver steatosis in patients with HIV infection.

C. Fìlice, D. Cattaneo, M. Galli, 2019, Pharmacological research.

Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report

C. Fìlice, D. Cattaneo, A. Riva, 2020, International journal of STD & AIDS.

Effect of hepatitis B and C clearance on atazanavir exposure

D. Cattaneo, L. Milazzo, C. Gervasoni, 2015, European Journal of Clinical Pharmacology.

Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients.

D. Cattaneo, L. Milazzo, C. Gervasoni, 2014, AIDS.

Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once.

C. Fìlice, D. Cattaneo, A. Riva, 2020, Journal of acquired immune deficiency syndromes.

Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens.

S. Antinori, D. Cattaneo, C. Gervasoni, 2021, AIDS.

Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.

D. Cattaneo, E. Suardi, S. Bossolasco, 2021, AIDS.

Determinants of bone diseases in tenofovir-treated HIV patients.

E. Clementi, D. Cattaneo, G. Rizzardini, 2016, AIDS.

Is it time to revise antiretrovirals dosing? A pharmacokinetic viewpoint

E. Clementi, D. Cattaneo, N. Charbe, 2014 .

Is it time to revise antiretrovirals dosing? a pharmacokinetic viewpoint.

E. Clementi, D. Cattaneo, N. Charbe, 2014, AIDS.

Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice

E. Clementi, A. Giacomelli, D. Cattaneo, 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Psychoactive drugs and HIV: are we sure to treat our patients adequately?

D. Cattaneo, G. Rizzardini, C. Gervasoni, 2018, AIDS.

Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring.

E. Clementi, D. Cattaneo, A. Kustermann, 2015, Therapeutic drug monitoring.

Cyclosporine Formulation and Kaposi’s Sarcoma after Renal Transplantation

N. Perico, G. Remuzzi, E. Gotti, 2005, Transplantation.

Delayed graft function in kidney transplantation

Giuseppe Remuzzi, Dario Cattaneo, Norberto Perico, 2004, The Lancet.

Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots

E. Clementi, D. Cattaneo, G. di Perri, 2015, Clinical chemistry and laboratory medicine.

Population Pharmacokinetics of Mycophenolic Acid

M. Pescovitz, K. Budde, P. Glander, 2008, Clinical pharmacokinetics.

Potential benefits and limits of psychopharmacological therapies in pervasive developmental disorders.

E. Clementi, M. Nobile, M. Molteni, 2014, Current Clinical Pharmacology.

Clinical features and outcomes of HIV patients with coronavirus disease 2019

A. Giacomelli, D. Cattaneo, A. Riva, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics

E. Clementi, P. Vitiello, D. Cattaneo, 2013, European Journal of Clinical Pharmacology.

Prolonged inductive effect of rifampicin on linezolid exposure

E. Clementi, D. Cattaneo, N. Charbe, 2015, European Journal of Clinical Pharmacology.

Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections.

E. Clementi, D. Cattaneo, G. Rizzardini, 2013, International journal of antimicrobial agents.

Prolonged inductive effect of rifampicin on linezolid exposure

E. Clementi, D. Cattaneo, N. Charbe, 2015, European Journal of Clinical Pharmacology.

Therapeutic drug management of linezolid: a missed opportunity for clinicians?

E. Clementi, D. Cattaneo, C. Gervasoni, 2016, International journal of antimicrobial agents.

Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations

D. Cattaneo, C. Gervasoni, Deborah J.E. Marriott, 2023, Expert review of clinical pharmacology.

Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?

E. Clementi, D. Cattaneo, C. Gervasoni, 2020, Clinical Pharmacokinetics.

Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid.

E. Clementi, D. Cattaneo, S. Baldelli, 2017, Therapeutic Drug Monitoring.

Comparison of the Arktm Immunoassay With Hplc-Uv for Therapeutic Drug Monitoring of Linezolid.

E. Clementi, D. Cattaneo, S. Baldelli, 2017, Therapeutic drug monitoring.

Is it time to revise linezolid dose in elderly patients?

D. Cattaneo, C. Gervasoni, M. Tinelli, 2017, European Journal of Clinical Pharmacology.

Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk: Effects of Acetyl-l-Carnitine Therapy

G. Remuzzi, P. Ruggenenti, N. Motterlini, 2009, Hypertension.

Pharmacogenetics of Immunosuppressants: Progress, Pitfalls and Promises

N. Perico, D. Cattaneo, S. Baldelli, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Human Borrelia miyamotoi Infection in the United States

D. Cattaneo, R. Agarwal, S. Dhooria, 2013 .

Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch

E. Clementi, M. Molteni, D. Cattaneo, 2016, Expert opinion on drug safety.

Inflammation and neurological adverse drugs reactions: a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis

E. Clementi, G. Zuccotti, D. Cattaneo, 2012, Italian Journal of Pediatrics.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy

D. Cattaneo, L. Milazzo, G. Rizzardini, 2015, European Journal of Clinical Pharmacology.

Intolerance of dolutegravir-containing combination antiretroviral therapy: not just a pharmacokinetic drug interaction.

D. Cattaneo, G. Rizzardini, C. Gervasoni, 2017, AIDS.

Management of Polypharmacy and Drug-Drug Interactions in HIV Patients: A 2-year Experience of a Multidisciplinary Outpatient Clinic

D. Cattaneo, C. Gervasoni, T. Formenti, 2019, AIDS reviews.

Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.

B. Dimitrov, N. Perico, G. Remuzzi, 2005, Transplantation proceedings.

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.

Dario Cattaneo, Eleonora Marrazzo, Massimo Broggini, 2008, European journal of cancer.

Darunavir does not prevent SARS-CoV-2 infection in HIV patients

D. Cattaneo, A. Riva, C. Gervasoni, 2020, Pharmacological Research.

Transplacental passage of ritonavir-boosted darunavir in two pregnant women

D. Cattaneo, F. Maggiolo, D. Ripamonti, 2009, International journal of STD & AIDS.

Steady State Pharmacokinetic of Ritonavir-boosted Atazanavir in 31 Pregnant Women before and after Delivery.

D. Cattaneo, F. Maggiolo, D. Ripamonti, 2010 .

Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?

U. Maggiore, E. Fiaccadori, S. Buti, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial.

T. Calimeri, F. Fallanca, A. Corti, 2020, Blood advances.

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.

T. Calimeri, F. Fallanca, A. Corti, 2019, Blood.

Diverse Effects of Increasing Lisinopril Doses on Lipid Abnormalities in Chronic Nephropathies

G. Remuzzi, P. Ruggenenti, A. Perna, 2003, Circulation.

Optimizing immunosuppressive drug dosing in pediatric renal transplantation. Part of a special series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.

D. Cattaneo, A. Vinks, 2012, Pharmacological research.

Ritonavir/Cobicistat-Induced Cushing Syndrome in HIV Patients Treated With Non-Oral Corticosteroids: A Call for Action?

C. Fìlice, A. Giacomelli, D. Cattaneo, 2020, The American journal of the medical sciences.

In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial.

B. Dimitrov, N. Perico, G. Remuzzi, 2004, Kidney international.

Two-hour post-dose cyclosporine monitoring does not fit all in kidney transplantation

N. Perico, G. Remuzzi, F. Gaspari, 2016 .

Emerging drugs for diabetic nephropathy

N. Perico, G. Remuzzi, S. Bruno, 2005, Expert opinion on emerging drugs.

Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review.

A. Martelli, C. Castellani, D. Cattaneo, 2021, International journal of antimicrobial agents.

Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.

N. Perico, D. Cattaneo, R. Fiocchi, 2006, Clinical biochemistry.

Aldosterone and progression of kidney disease

N. Perico, G. Remuzzi, D. Cattaneo, 2009, Therapeutic advances in cardiovascular disease.

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders

R. Testi, D. Cattaneo, G. di Perri, 2020, Antimicrobial Agents and Chemotherapy.

A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication.

D. Cattaneo, E. Suardi, S. Bossolasco, 2020, Therapeutic drug monitoring.

Multidrug-resistant HIV viral rebound during early syphilis: a case report

A. Giacomelli, D. Cattaneo, C. Gervasoni, 2020, BMC Infectious Diseases.

The impact of gastrectomy on the pharmacokinetics of atazanavir and tenofovir

D. Cattaneo, A. Riva, C. Gervasoni, 2017, European Journal of Clinical Pharmacology.

From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy

N. Perico, G. Remuzzi, D. Cattaneo, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives

N. Perico, G. Remuzzi, D. Cattaneo, 2004 .

Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations.

M. Broggini, G. Damia, F. Ricci, 2011, European journal of cancer.

Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development

P. Horby, C. Flexner, E. Acosta, 2020, Clinical pharmacology and therapeutics.

Investigational drugs for diabetic nephropathy

N. Perico, G. Remuzzi, D. Cattaneo, 2008, Expert opinion on investigational drugs.

Pharmacokinetic drug evaluation of dolutegravir plus rilpivirine for the treatment of HIV

D. Cattaneo, G. Rizzardini, A. Capetti, 2017, Expert opinion on drug metabolism & toxicology.

Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project

D. Cattaneo, M. Wolkewitz, S. Harbarth, 2020, The Journal of antimicrobial chemotherapy.

Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV

D. Cattaneo, C. Spinner, C. Hoffmann, 2020, HIV medicine.

Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272

S. Ludovisi, D. Cattaneo, A. Gori, 2021, International Journal of Infectious Diseases.

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

D. Marriott, M. Neely, D. Cattaneo, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round.

D. Cattaneo, A. Corona, A. Agarossi, 2020, Therapeutic drug monitoring.

Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects.

E. Clementi, E. Mazzon, S. Cuzzocrea, 2009, Pharmacological research.

Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance

D. Cattaneo, M. Mauri, A. Reggiori, 2020, Pharmacopsychiatry.

Effects of the androgen receptor inhibitor enzalutamide on the pharmacokinetics of dolutegravir and tenofovir: a case report.

D. Cattaneo, C. Tascini, C. Gervasoni, 2022, AIDS.

No effects of Hypericum-containing complex on dolutegravir plasma trough concentrations: a case report

D. Cattaneo, C. Gervasoni, M. Fusi, 2019, European Journal of Clinical Pharmacology.

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings

C. Fìlice, D. Cattaneo, L. Milazzo, 2020, Drugs in R&D.

Selective serotonin reuptake inhibitors’ passage into human milk of lactating women

E. Clementi, G. Zuccotti, I. Cetin, 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study.

E. Clementi, A. de Silvestri, D. Dilillo, 2023, The pharmacogenomics journal.

Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects

E. Clementi, D. Cattaneo, C. Vantaggiato, 2022, Cardiovascular research.

Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor

D. Cattaneo, C. Gervasoni, 2018, European Journal of Drug Metabolism and Pharmacokinetics.

Chronic Allograft Nephropathy (CAN) - An Update

D. Cattaneo, D. Goldsmith, Thomas Oates, 2008 .

The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions

E. Clementi, M. Molteni, D. Cattaneo, 2017, The Pharmacogenomics Journal.

Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19

A. Giacomelli, D. Cattaneo, A. Riva, 2020 .

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients

D. Fuchs, A. Lazzarin, H. Zetterberg, 2016, Medicine.

Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life Investigation.

C. Fìlice, D. Cattaneo, C. Gervasoni, 2019, Therapeutic drug monitoring.

Optimization of cyclosporine therapy in the Neoral era: abbreviated AUC, single blood sampling?

N. Perico, G. Remuzzi, F. Gaspari, 2001, Transplantation proceedings.

Lights and Shadows of the Actual European Guidelines on Bioanalytical Method Validation: The Case of Raltegravir

E. Clementi, D. Cattaneo, S. Baldelli, 2014, Therapeutic drug monitoring.

ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?

E. Clementi, D. Cattaneo, L. Ferraris, 2013, European Journal of Clinical Pharmacology.

Reply to Childs et al.

D. Cattaneo, C. Gervasoni, P. Meraviglia, 2020, Clinical Infectious Diseases.

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers

E. Clementi, D. Cattaneo, A. Capetti, 2014, Drug design, development and therapy.

Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.

E. Clementi, M. Molteni, D. Cattaneo, 2016, The Journal of clinical psychiatry.

Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper

D. Cattaneo, D. Marriott, 2023, Therapeutic drug monitoring.

Therapeutic drug monitoring of TNFα inhibitors: a spotlight on novel techniques and assays

D. Cattaneo, J. Cusato, 2022, Expert opinion on drug metabolism & toxicology.

Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation

D. Mari, A. Altamura, D. Cattaneo, 2016, Human psychopharmacology.

Pharmacovigilance knowledge in family paediatricians. A survey study in Italy.

Paolo Pellegrino, Dario Cattaneo, Emilio Clementi, 2013, Health policy.

Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine

E. Clementi, S. Bruno, C. Mameli, 2012, Clinical kidney journal.

Dolutegravir Plasma Concentrations According to Companion Antiretroviral Drug: Unwanted Drug Interaction or Desirable Boosting Effect?

E. Clementi, D. Cattaneo, A. Riva, 2017, Antiviral therapy.

Serotonin Reuptake Inhibitors in Pregnancy: Can Genes Help Us in Predicting Neonatal Adverse Outcome?

D. Dilillo, G. Zuccotti, D. Cattaneo, 2014, BioMed research international.

The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly

D. Cattaneo, M. Mauri, S. Baldelli, 2021, Journal of clinical psychopharmacology.

Acute generalized exanthematous pustulosis induced by paroxetine in an adolescent girl.

C. Mameli, G. Zuccotti, D. Cattaneo, 2013, Acta dermato-venereologica.

Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations: A Case Series of Bipolar Type 2 Patients

E. Clementi, A. Altamura, D. Cattaneo, 2017, Drug Safety - Case Reports.

Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient

E. Clementi, D. Cattaneo, N. Charbe, 2016, European Journal of Clinical Pharmacology.

Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis?

D. Cattaneo, A. Riva, M. Galli, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational Study.

E. Clementi, A. Altamura, D. Cattaneo, 2017, Therapeutic drug monitoring.

Polypharmacy and Aging in People Living with HIV: 6 Years of Experience in a Multidisciplinary Outpatient Clinic

S. Antinori, D. Cattaneo, A. Gori, 2023, Drugs & Aging.

Seizures in Patients with Chronic Hepatitis C Treated with NS3/4A Protease Inhibitors: Does Pharmacological Interaction Play a Role?

S. Antinori, D. Cattaneo, L. Milazzo, 2013, Pharmacology.

Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma

E. Clementi, D. Cattaneo, N. Charbe, 2016, Therapeutic drug monitoring.

Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection.

N. Perico, D. Cattaneo, F. Maggiolo, 2008, Journal of chromatographic science.

Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction.

E. Clementi, D. Cattaneo, A. Riva, 2016, Therapeutic drug monitoring.

Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report

C. Fìlice, D. Cattaneo, C. Gervasoni, 2020, European Journal of Clinical Pharmacology.

Effect of doravirine on dolutegravir trough concentrations in people with HIV switched from darunavir/cobicistat.

S. Antinori, D. Cattaneo, A. Gori, 2023, The Journal of antimicrobial chemotherapy.

Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma.

E. Clementi, D. Cattaneo, F. Violi, 2016, Bioanalysis.

Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges

E. Clementi, G. Zuccotti, D. Cattaneo, 2023, Pharmaceutics.

Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women.

D. Cattaneo, A. Riva, M. Galli, 2013, The Journal of antimicrobial chemotherapy.

High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus.

N. Perico, G. Remuzzi, D. Cattaneo, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis

E. Clementi, D. Cattaneo, C. Colombo, 2019, Clinical chemistry and laboratory medicine.

Is it time to revise linezolid dose in elderly patients?

D. Cattaneo, C. Gervasoni, M. Tinelli, 2017, European Journal of Clinical Pharmacology.

Orlistat: weight lost at cost of HIV rebound.

E. Clementi, D. Cattaneo, A. Riva, 2016, The Journal of antimicrobial chemotherapy.

Dosing Colistin Properly: Let's Save "Our Last Resort Old Drug!"

D. Cattaneo, A. Corona, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Development and Validation of a Chromatographic Ultraviolet Method for the Quantification of Isavuconazole in Human Plasma Samples.

E. Clementi, D. Cattaneo, S. Baldelli, 2018, Therapeutic drug monitoring.

Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor—Free Regimen

N. Perico, G. Remuzzi, E. Gotti, 2009, Journal of clinical pharmacology.

Potential Association between Rosuvastatin use and High Atazanavir trough Concentrations in Ritonavir-Treated HIV-Infected Patients

E. Clementi, D. Cattaneo, A. Riva, 2015, Antiviral therapy.

Are non-serious adverse reactions to psychiatric drugs really non-serious?

E. Clementi, M. Molteni, D. Cattaneo, 2013, Journal of child and adolescent psychopharmacology.

Do lopinavir and ritonavir require a dose adjustment during pregnancy?

D. Cattaneo, D. Ripamonti, 2014, Journal of Acquired Immune Deficiency Syndromes.

Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review

S. Antinori, C. Cogliati, D. Cattaneo, 2023, Antibiotics.

E. Clementi, D. Cattaneo, C. Gervasoni, 2015, European Journal of Clinical Pharmacology.

Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review

N. Latronico, D. Cattaneo, A. Corona, 2023, Antibiotics.

Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient

D. Cattaneo, C. Gervasoni, Martina Beltrami, 2023, European Journal of Clinical Pharmacology.

Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action

A. Giacomelli, D. Cattaneo, C. Gervasoni, 2021, Clinical Gastroenterology and Hepatology.

Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders.

S. Antinori, D. Cattaneo, C. Mazzali, 2015, International journal of antimicrobial agents.

Liver Injury After Occasional Energy Drink Use in a Patient Living With HIV and Diabetes

C. Fìlice, D. Cattaneo, A. Riva, 2020, The Annals of pharmacotherapy.

Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients.

D. Cattaneo, A. D’Avolio, L. Milazzo, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of hepatitis B and C clearance on atazanavir exposure

D. Cattaneo, L. Milazzo, C. Gervasoni, 2015, European Journal of Clinical Pharmacology.

Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.

D. Cattaneo, D. Ricaboni, C. Gervasoni, 2016, Journal of Clinical Virology.

Association of HIV Infection with Epilepsy and Other Comorbid Conditions

A. Giacomelli, D. Cattaneo, C. Gervasoni, 2019, Aids and Behavior.

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.

G. Remuzzi, M. Abbate, D. Cattaneo, 2002, Journal of the American Society of Nephrology.

The aggravating mechanisms of aldosterone on kidney fibrosis.

N. Perico, G. Remuzzi, D. Cattaneo, 2008, Journal of the American Society of Nephrology : JASN.

The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report

E. Clementi, D. Cattaneo, C. Altamura, 2017, Journal of clinical pharmacy and therapeutics.

Pharmacokinetic drug evaluation of dolutegravir plus rilpivirine for the treatment of HIV

D. Cattaneo, G. Rizzardini, A. Capetti, 2017, Expert opinion on drug metabolism & toxicology.

Effect of N-Desalkylquetiapine / Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disoder : A Prospective Observational Study

E. Clementi, A. Altamura, D. Cattaneo, 2017 .

Lipid oxidative stress and the anti-inflammatory properties of statins and ACE inhibitors.

G. Remuzzi, D. Cattaneo, 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Pharmacokinetic concerns related to the AIDS Clinical Trial Group (ACTG) A5262 trial.

D. Cattaneo, C. Gervasoni, 2012, AIDS.

Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report

E. Clementi, D. Cattaneo, L. Norsa, 2022, European Journal of Clinical Pharmacology.

Generic cyclosporine formulations: more open questions than answers

N. Perico, G. Remuzzi, D. Cattaneo, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Elvitegravir/Cobicistat-Associated Toxic Optical Neuropathy in an HIV-Infected Patient: A Call for Caution?

D. Cattaneo, A. Invernizzi, A. Riva, 2016, Antiviral therapy.

How relevant are the drug–drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?

D. Cattaneo, C. Gervasoni, A. Ridolfo, 2018, The Journal of antimicrobial chemotherapy.